Mylan N.V. (MYL) financial statements (2021 and earlier)

Company profile

Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY
HATFIELD, HERTFORDSHIRE, AL10 9UL
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments476359212230388486366
Cash and cash equivalents476359212230388449330
Short-term investments     3736
Restricted cash and investments16161115454
Receivables2,6402,5472,2772,3672,4172,5912,477
Inventory, net of allowances, customer advances and progress billings2,6712,7642,7762,7092,5802,5612,561
Inventory2,6712,7642,7762,7092,5802,5612,561
Prepaid expense157154154132131117135
Other current assets271284301311295343315
Other undisclosed current assets528523545513556390391
Total current assets:6,7576,6456,2656,2626,3686,5426,298
Noncurrent Assets
Property, plant and equipment2,1502,1242,1462,1512,1702,1202,186
Intangible assets, net (including goodwill)21,24121,21122,42422,56323,41224,03624,033
Goodwill9,5919,3879,6939,6089,7489,7979,881
Intangible assets, net (excluding goodwill)11,65011,82412,73112,95613,66514,23914,153
Regulated entity, other noncurrent assets59   74  
Other noncurrent assets405445429422212245286
Deferred tax assets, net628553508 514468
Other undisclosed noncurrent assets644   499  
Total noncurrent assets:24,49824,40825,55225,64426,36726,91426,974
TOTAL ASSETS:31,25631,05431,81731,90732,73533,45633,272
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7411,6651,6771,3401,7391,4771,369
Accounts payable1,5281,5111,5381,3171,6171,4011,342
Taxes payable213153139231227627
Other liabilities2,3202,3752,1332,1142,1482,5282,072
Other undisclosed current liabilities1,5086057517047021,1771,422
Total current liabilities:5,5694,6454,5604,1584,5885,1824,863
Noncurrent Liabilities
Long-term debt and lease obligation11,21412,46112,59013,08713,16113,29113,320
Long-term debt, excluding current maturities11,21412,46112,59013,08713,16113,29113,320
Liabilities, other than long-term debt, including:798425423724023748
Deferred tax liabilities, net1,6281,5571,6351,6431,7221,7641,824
Liability for uncertainty in income taxes110756476162156164
Liability, pension and other postretirement and postemployment benefits409383393390398412408
Other liabilities9619281,1291,1271,0971,1521,055
Other undisclosed liabilities, other than long-term debt(3,028)(2,859)(2,968)(3,000)(3,139)(3,246)(3,404)
Other undisclosed noncurrent liabilities2,5092,4012,5102,5342,5792,6792,832
Total noncurrent liabilities:13,80314,94515,35415,85715,98016,20716,200
Total liabilities:19,37219,59019,91420,01520,56821,38921,063
Stockholders' equity
Stockholders' equity attributable to parent11,88411,463(2,402)(2,598)12,16712,06612,209
Common stock66  666
Treasury stock, value(1,000)(1,000)(1,000)(1,000)(1,000)(1,000)(1,000)
Additional paid in capital8,6448,638  8,5918,5858,613
Accumulated other comprehensive loss(1,797)(2,191)(1,402)(1,599)(1,441)(1,491)(1,199)
Retained earnings6,0316,011  6,0115,9665,789
Other undisclosed stockholders' equity  14,30414,490   
Total stockholders' equity:11,88411,46311,90311,89212,16712,06612,209
TOTAL LIABILITIES AND EQUITY:31,25631,05431,81731,90732,73533,45633,272

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues3,1922,9622,8522,4963,0792,8622,808
Revenue, net4,8022,808
Cost of revenue
(Cost of Goods and Services Sold)
(2,104)(1,889)(1,919)(1,690)(2,063)(1,823)(1,846)
Gross profit:1,0871,0729338051,0161,039963
Operating expenses(815)(749)(837)(781)(783)(701)(784)
Operating income:2723249624233338179
Nonoperating expense
(Other Nonoperating expense)
(11)(9)(16)(7)(21)(10)(21)
Interest and debt expense(126)(129)(131)(131)(135)(136)(139)
Income (loss) from continuing operations before income taxes:135186(52)(115)7719219
Income tax expense (benefit)(115)4(116)90(26)(16)19
Net income (loss) available to common stockholders, diluted:21190(169)(25)5117738

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):21190(169)(25)5117738
Other comprehensive income (loss)394(650)169(266)50(292)(1,008)
Comprehensive income (loss), net of tax, attributable to parent:415(460)0(291)101(115)(970)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: